ABH Healthcare
Upcoming24–26 Aug 2026
Updated 2026-08-21 (IST)
Business overview
ABH Healthcare Limited provides specialised tertiary medical care in Tier 3 cities within the state of Punjab, operating under the 'Anil Baghi Hospital' brand. Located in Ferozepur, Punjab, the hospital has a capacity of 150 beds and offers 25 medical specialties, including cardiac sciences, neurology, orthopedics, and general surgery.
Profit & Loss
Rs crore · AnnualLatest year highlighted in green. Sparklines show the trend.
| 2024 | 2025 | 2026 | ||
|---|---|---|---|---|
| Sales | 41 | 49 | 53 | |
| Operating Profit | — | — | — | |
| OPM % | — | — | — | |
| Net Profit | — | — | — | |
| Total Debt | 36 | 42 | 55 |
Promoters
- Dr. Kamal Baghi — Chairman and Whole-time Director
- Dr. Saurabh Baghi — Managing Director
- Dr. Vaishali Saini — Non-Executive Director
Strengths & risks
Company-stated strengths and disclosed risk factors from the offer document.
- Doctor led professional management team with proven execution capabilities. (p.126)
- Delivering quality clinical care by attracting and retaining experienced and renowned clinicians. (p.127)
- Diversified operations across clinical specialties, payor mix and hospitals. (p.127)
- Our revenues are significantly dependent on our only hospital in Ferozepur, Punjab. (p.29)
- We may be unable to keep pace with technological changes, new equipment, and evolving industry standards. (p.29)
- We operate in a highly regulated industry, and compliance with safety, health, and environmental regulations is costly. (p.31)
- We do not own the premises where our Registered Office and hospital are located. (p.33)
- We have a high debt-equity ratio and may face certain funding risks. (p.34)
Peer comparison — DRHP median P/E 26.1x
Live BSE prices| Company | CMP | P/E | OPM% | ROE% | Source |
|---|---|---|---|---|---|
| Sangani Hospitals Limited | — | 24.5x | — | — | DRHP |
| Maitreya Medicare Limited | — | -34.1x | — | — | DRHP |
| Asarfi Hospital Limited | Rs 221.4 -5.3% | 27.6x | — | — | live |
P/E from offer document where live data unavailable. Not a fair-value judgement.
Market & competition
In 2022, the company was recognized as the leading hospital in Punjab among 720 hospitals empaneled with the State Health Agency, Punjab, and the National Health Authority.
Future outlook
The company plans to invest further in advanced medical technology to enhance its currently functioning departments and increase the range of services offered. It also plans to add two new specialties pertaining to oncology and Cardio-Thoracic & Vascular Surgery in the near future.
Never miss an IPO like this
Every upcoming IPO analysed — subscription, GMP and a DRHP breakdown — in your inbox, free. One email when each one opens.
Sources & method
Subscription and issue data come from the NSE and BSE exchange feeds, with the third-party aggregator, clearly labelled, where an exchange feed is unreachable. DRHP analysis is extracted from the offer document itself, every figure cited to its page. Each figure on the page carries its source and its timestamp.
Grey-market premium (GMP) is unregulated.
Every GMP figure is a self-reported grey-market estimate — no exchange, regulator or clearing body records or audits it, and there is no settlement guarantee or recourse. Shown for context only; never decide on GMP alone. New to GMP? The 30-second explainer →